Epi Soul logo image Epi Soul logo image
  1. UW Home |
  2. SPH  |
  3. Other Departments |
Loading
online giving









































David A. Shoultz, MBA, PhD, MS, BSN


Affiliate Assistant Professor, Epidemiology (primary department)
Affiliate Assistant Professor, Global Health


Deputy Director, Global Health, Infectious Disease Development


Contact Information
Bill and Melinda Gates Foundation
Global Health, Infectious Disease Development
PO Box 23350
Seattle, WA 98102
Tel: 206-709-3307
Fax: 206-494-7039
http://www.gatesfoundation.org
david.shoultz@gatesfoundation.org


Research Interests
New medicines & vaccine development for infectious diseases, HIV and other sexually transmitted infections, business and finance of new medicines & vaccine development, sustainable models of new medicines & vaccine development for the developing world, and local life sciences development. Always interested in talking and working with students sharing these research interests or considering a similar career area.

Other Areas of Involvement

Board of Directors and Inaugural Chair of the Scientific Advisory Board, the Geneva Foundation - a private, non-profit organization created in 1993 with the sole purpose to support and promote the advancement of military medicine. www.genevausa.org

Education
MBA, Seattle University, Albers School of Business & Economics, 2012
PhD, Epidemiology, University of Washington 1997
MS, Epidemiology, University of Washington 1995
BSN, University of Washington, School of Nursing 1991

Selected Publications
Bio now or never: Tacoma must act quickly or risk losing out on biosciences surge (invited OpEd). Tacoma Tribune. September 26, 2004.

Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemo. 2003 51: 1261-1268.

Palmon R, Koo BC, Shoultz DA, Dieterich DT. Lack of hepatotoxicity associated with nonnucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):340-5.

Rogers WJ, Canto JG, Lambrew CT, Tiefenbrunn AJ, Kinkaid B, Shoultz DA, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000 Dec;36(7):2056-63.

Cannon, CP, Gibson CM, Lambrew CT, Shoultz DA, et al. Relationship of symptom-onset-to-balloon-time and door-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000 Jun 14; 283(22):2941-7.

Rogers WJ, Canto JG, Barron HV, Boscarino JA, Shoultz DA, Every NR. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction. J Am Coll Cardiol 2000 Feb;35(2):371-9.

Bratton, S.L., D.A. Shoultz, M.A. Williams. 1996. Recurrent risk of low birth weight deliveries among women with a prior very low birth weight delivery. Am J Perinatol 13:147-50.

Shoultz, D.A., L.A. Koutsky, D.A. Galloway. 1996. Epidemiology and Modes and Transmission. Book Chapter In: Human Papillamavirus Infections in Dermatovenereology (Gross, G., G. vonKrogh, Eds.)

FacBio XML parser code Epi